Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Catheter Precision (VTAK) EBIAT (2017 - 2025)

Catheter Precision (VTAK) has disclosed EBIAT for 9 consecutive years, with -$6.3 million as the latest value for Q4 2025.

  • Quarterly EBIAT fell 11.85% to -$6.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$18.0 million through Dec 2025, down 8.45% year-over-year, with the annual reading at -$17.7 million for FY2025, 6.35% down from the prior year.
  • EBIAT for Q4 2025 was -$6.3 million at Catheter Precision, down from -$2.3 million in the prior quarter.
  • The five-year high for EBIAT was -$669000.0 in Q4 2023, with the low at -$66.4 million in Q1 2023.
  • Average EBIAT over 5 years is -$7.9 million, with a median of -$5.0 million recorded in 2021.
  • The sharpest move saw EBIAT tumbled 1108.37% in 2023, then skyrocketed 95.97% in 2024.
  • Over 5 years, EBIAT stood at -$8.3 million in 2021, then increased by 1.54% to -$8.2 million in 2022, then skyrocketed by 91.8% to -$669000.0 in 2023, then crashed by 741.26% to -$5.6 million in 2024, then fell by 11.85% to -$6.3 million in 2025.
  • According to Business Quant data, EBIAT over the past three periods came in at -$6.3 million, -$2.3 million, and -$5.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.